-
1
-
-
33646852746
-
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002
-
Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ,. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144 (10): 705-714. (Pubitemid 46780630)
-
(2006)
Annals of Internal Medicine
, vol.144
, Issue.10
, pp. 705-714
-
-
Armstrong, G.L.1
Wasley, A.2
Simard, E.P.3
McQuillan, G.M.4
Kuhnert, W.L.5
Alter, M.J.6
-
2
-
-
55249124547
-
HIV prevalence estimates - United States, 2006
-
Campsmith ML, Rhodes P, Hall HI, Green T,. HIV prevalence estimates-United States, 2006. MMWR Morb Mortal Wkly Rep 2008; 57 (39): 1073-1076.
-
(2008)
MMWR Morb Mortal Wkly Rep
, vol.57
, Issue.39
, pp. 1073-1076
-
-
Campsmith, M.L.1
Rhodes, P.2
Hall, H.I.3
Green, T.4
-
3
-
-
0032538246
-
Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention
-
Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998; 47 (RR-19): 1-39.
-
(1998)
MMWR Recomm Rep
, vol.47
, Issue.RR-19
, pp. 1-39
-
-
-
4
-
-
0642303165
-
The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update
-
El-Serag HB, Davila JA, Petersen NJ, McGlynn KA,. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003; 139 (10): 817-823.
-
(2003)
Ann Intern Med
, vol.139
, Issue.10
, pp. 817-823
-
-
El-Serag, H.B.1
Davila, J.A.2
Petersen, N.J.3
McGlynn, K.A.4
-
5
-
-
54049153227
-
Validation of a hepatitis C screening tool in primary care
-
McGinn T, O'Connor-Moore N, Alfandre D, Gardenier D, Wisnivesky J,. Validation of a hepatitis C screening tool in primary care. Arch Intern Med 2008; 168 (18): 2009-2013.
-
(2008)
Arch Intern Med
, vol.168
, Issue.18
, pp. 2009-2013
-
-
McGinn, T.1
O'Connor-Moore, N.2
Alfandre, D.3
Gardenier, D.4
Wisnivesky, J.5
-
6
-
-
0035934568
-
Peginterferon alfa-2b plus ribavirin compared with interferonalfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
-
DOI 10.1016/S0140-6736(01)06102-5
-
Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358 (9286): 958-965. (Pubitemid 32913521)
-
(2001)
Lancet
, vol.358
, Issue.9286
, pp. 958-965
-
-
Manns, M.P.1
McHutchison, J.G.2
Gordon, S.C.3
Rustgi, V.K.4
Shiffman, M.5
Reindollar, R.6
Goodman, Z.D.7
Koury, K.8
Ling, M.-H.9
Albrecht, J.K.10
-
7
-
-
0037179698
-
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
-
Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347 (13): 975-982.
-
(2002)
N Engl J Med
, vol.347
, Issue.13
, pp. 975-982
-
-
Fried, M.W.1
Shiffman, M.L.2
Reddy, K.R.3
-
8
-
-
1542378867
-
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment duration and ribavirin dose
-
Hadziyannis SJ, Sette H Jr, Morgan TR, et al. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 2004; 140 (5): 346-355.
-
(2004)
Ann Intern Med
, vol.140
, Issue.5
, pp. 346-355
-
-
Hadziyannis, S.J.1
Sette, Jr.H.2
Morgan, T.R.3
-
9
-
-
1842479859
-
Diagnosis, management, and treatment of Hepatitis C
-
DOI 10.1002/hep.20119
-
Strader DB, Wright T, Thomas DL, Seeff LB,. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004; 39 (4): 1147-1171. (Pubitemid 38428955)
-
(2004)
Hepatology
, vol.39
, Issue.4
, pp. 1147-1171
-
-
Strader, D.B.1
Wright, T.2
Thomas, D.L.3
Seeff, L.B.4
-
10
-
-
65449136656
-
Diagnosis, management, and treatment of hepatitis C: An update
-
Ghany MG, Strader DB, Thomas DL, Seeff LB,. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49 (4): 1335-1374.
-
(2009)
Hepatology
, vol.49
, Issue.4
, pp. 1335-1374
-
-
Ghany, M.G.1
Strader, D.B.2
Thomas, D.L.3
Seeff, L.B.4
-
11
-
-
73149113990
-
Public health impact of antiviral therapy for hepatitis C in the United States
-
Volk ML, Tocco R, Saini S, Lok AS,. Public health impact of antiviral therapy for hepatitis C in the United States. Hepatology 2009; 50 (6): 1750-1755.
-
(2009)
Hepatology
, vol.50
, Issue.6
, pp. 1750-1755
-
-
Volk, M.L.1
Tocco, R.2
Saini, S.3
Lok, A.S.4
-
12
-
-
0033792571
-
Evaluation of the effectiveness of targeted lookback for HCV infection in the United States-interim results
-
Culver DH, Alter MJ, Mullan RJ, Margolis HS,. Evaluation of the effectiveness of targeted lookback for HCV infection in the United States-interim results. Transfusion 2000; 40 (10): 1176-1181.
-
(2000)
Transfusion
, vol.40
, Issue.10
, pp. 1176-1181
-
-
Culver, D.H.1
Alter, M.J.2
Mullan, R.J.3
Margolis, H.S.4
-
13
-
-
0033375483
-
Cost-effectiveness of screening patients for hepatitis C
-
Gordon FD,. Cost-effectiveness of screening patients for hepatitis C. Am J Med 1999; 107 (6B): 36S-40S.
-
(1999)
Am J Med
, vol.107
, Issue.6 B
-
-
Gordon, F.D.1
-
14
-
-
67449107308
-
Factors associated with awareness of infection status among chronic hepatitis B and C carriers in Korea
-
Shin A, Cho ER, Kim J, et al. Factors associated with awareness of infection status among chronic hepatitis B and C carriers in Korea. Cancer Epidemiol Biomarkers Prev 2009; 18 (6): 1894-1898.
-
(2009)
Cancer Epidemiol Biomarkers Prev
, vol.18
, Issue.6
, pp. 1894-1898
-
-
Shin, A.1
Cho, E.R.2
Kim, J.3
-
15
-
-
0030912791
-
Hepatitis C in a French population-based survey, 1994: Seroprevalence, frequency of viremia, genotype distribution, and risk factors
-
DOI 10.1002/hep.510250630
-
Dubois F, Desenclos JC, Mariotte N, Goudeau A,. Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group. Hepatology 1997; 25 (6): 1490-1496. (Pubitemid 27250774)
-
(1997)
Hepatology
, vol.25
, Issue.6
, pp. 1490-1496
-
-
Dubois, F.1
Desenclos, J.-C.2
Mariotte, N.3
Goudeau, A.4
Drucker, J.5
Guignard, E.6
Buzelay, L.7
Allemand, H.8
Giordanella, J.P.9
Tichet, J.10
Thevenas, C.11
Caces, E.12
Jacquelin, J.M.13
Arondel, D.14
Calvet, C.15
Lemauff, J.M.16
Lepinay, P.17
Novak, M.18
Varsat, B.19
Rene, M.N.20
Tilliet, J.P.21
Raboutet, P.22
Leray, P.23
Janer, P.24
Pot, A.M.25
Fournier, B.26
Maltesse, G.27
Campion, J.28
Lebrun, I.29
Henny, J.30
Aubry, C.31
Deforges, D.32
Radel, N.33
Seyve, D.34
Didelot, R.35
Pignol, A.M.36
Gomez, P.37
Estopina-Gil, A.M.38
Lebas, A.M.39
more..
-
16
-
-
0033406371
-
EASL International Consensus Conference on hepatitis C. Paris, 26-27 February 1999. Consensus statement
-
EASL International Consensus Conference on hepatitis C. Paris, 26-27 February 1999. Consensus statement. J Hepatol 1999; 31 (Suppl 1): 3-8.
-
(1999)
J Hepatol
, vol.31
, Issue.SUPPL. 1
, pp. 3-8
-
-
-
17
-
-
0031837391
-
French consensus conference on hepatitis C: Screening and treatment
-
Galmiche JP,. French consensus conference on hepatitis C: screening and treatment. Gut 1998; 42 (6): 892-898. (Pubitemid 28277236)
-
(1998)
Gut
, vol.42
, Issue.6
, pp. 892-898
-
-
Galmiche, J.P.1
-
18
-
-
0005063278
-
Hepatitis C infection risk analysis: Who should be screened? Comparison of multiple screening strategies based on the national hepatitis surveillance program
-
DOI 10.1111/j.1572-0241.1998.170-b.x, PII S0002927098000471
-
Lapane KL, Jakiche AF, Sugano D, Weng CS, Carey WD,. Hepatitis C infection risk analysis: who should be screened? Comparison of multiple screening strategies based on the National Hepatitis Surveillance Program. Am J Gastroenterol 1998; 93 (4): 591-596. (Pubitemid 29081008)
-
(1998)
American Journal of Gastroenterology
, vol.93
, Issue.4
, pp. 591-596
-
-
Lapane, K.L.1
Jakiche, A.F.2
Sugano, D.3
Weng, C.S.W.4
Carey, W.D.5
-
19
-
-
0035700211
-
Cost effectiveness of screening for hepatitis C virus in asymptomatic, average-risk adults
-
DOI 10.1016/S0002-9343(01)00951-2, PII S0002934301009512
-
Singer ME, Younossi ZM,. Cost effectiveness of screening for hepatitis C virus in asymptomatic, average-risk adults. Am J Med 2001; 111 (8): 614-621. (Pubitemid 34088071)
-
(2001)
American Journal of Medicine
, vol.111
, Issue.8
, pp. 614-621
-
-
Singer, M.E.1
Younossi, Z.M.2
-
20
-
-
66249106683
-
Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection
-
Sroczynski G, Esteban E, Conrads-Frank A, et al. Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection. Eur J Public Health 2009; 19 (3): 245-253.
-
(2009)
Eur J Public Health
, vol.19
, Issue.3
, pp. 245-253
-
-
Sroczynski, G.1
Esteban, E.2
Conrads-Frank, A.3
-
22
-
-
0025933908
-
Antibody to hepatitis C is common among patients with alcoholic liver disease with and without risk factors
-
Caldwell SH, Jeffers LJ, Ditomaso A, et al. Antibody to hepatitis C is common among patients with alcoholic liver disease with and without risk factors. Am J Gastroenterol 1991; 86 (9): 1219-1223.
-
(1991)
Am J Gastroenterol
, vol.86
, Issue.9
, pp. 1219-1223
-
-
Caldwell, S.H.1
Jeffers, L.J.2
Ditomaso, A.3
-
23
-
-
0027498436
-
Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases
-
DOI 10.1001/jama.269.3.392
-
Weinstock HS, Bolan G, Reingold AL, Polish LB,. Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases. JAMA 1993; 269 (3): 392-394. (Pubitemid 23018080)
-
(1993)
Journal of the American Medical Association
, vol.269
, Issue.3
, pp. 392-394
-
-
Weinstock, H.S.1
Bolan, G.2
Reingold, A.L.3
Polish, L.B.4
-
24
-
-
0028922668
-
Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore - An analysis of 309 sex partnerships
-
Thomas DL, Zenilman JM, Alter HJ, et al. Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore-an analysis of 309 sex partnerships. J Infect Dis 1995; 171 (4): 768-775.
-
(1995)
J Infect Dis
, vol.171
, Issue.4
, pp. 768-775
-
-
Thomas, D.L.1
Zenilman, J.M.2
Alter, H.J.3
-
25
-
-
0344407045
-
Evaluation of screening criteria to identify persons with hepatitis C virus infection among sexually transmitted disease clinic clients: Results from the San Diego Viral Hepatitis Integration Project
-
DOI 10.1097/00007435-200304000-00013
-
Gunn RA, Murray PJ, Brennan CH, Callahan DB, Alter MJ, Margolis HS,. Evaluation of screening criteria to identify persons with hepatitis C virus infection among sexually transmitted disease clinic clients: results from the San Diego Viral Hepatitis Integration Project. Sex Transm Dis 2003; 30 (4): 340-344. (Pubitemid 36397837)
-
(2003)
Sexually Transmitted Diseases
, vol.30
, Issue.4
, pp. 340-344
-
-
Gunn, R.A.1
Murray, P.J.2
Brennan, C.H.3
Callahan, D.B.4
Alter, M.J.5
Margolis, H.S.6
-
26
-
-
54349115137
-
Guideline-concordant hepatitis C virus testing and notification among patients with and without mental disorders
-
Kilbourne AM, McCarthy JF, Himelhoch S, Welsh D, Hauser P, Blow FC,. Guideline-concordant hepatitis C virus testing and notification among patients with and without mental disorders. Gen Hosp Psychiatry 2008; 30 (6): 495-500.
-
(2008)
Gen Hosp Psychiatry
, vol.30
, Issue.6
, pp. 495-500
-
-
Kilbourne, A.M.1
McCarthy, J.F.2
Himelhoch, S.3
Welsh, D.4
Hauser, P.5
Blow, F.C.6
-
27
-
-
61849085819
-
Understanding associations between serious mental illness and hepatitis C virus among veterans: A national multivariate analysis
-
Himelhoch S, McCarthy JF, Ganoczy D, et al. Understanding associations between serious mental illness and hepatitis C virus among veterans: a national multivariate analysis. Psychosomatics 2009; 50 (1): 30-37.
-
(2009)
Psychosomatics
, vol.50
, Issue.1
, pp. 30-37
-
-
Himelhoch, S.1
McCarthy, J.F.2
Ganoczy, D.3
-
28
-
-
0035163889
-
Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness
-
Rosenberg SD, Goodman LA, Osher FC, et al. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health 2001; 91 (1): 31-37. (Pubitemid 32049263)
-
(2001)
American Journal of Public Health
, vol.91
, Issue.1
, pp. 31-37
-
-
Rosenberg, S.D.1
Goodman, L.A.2
Osher, F.C.3
Swartz, M.S.4
Essock, S.M.5
Butterfield, M.I.6
Constantine, N.T.7
Wolford, G.L.8
Salyers, M.P.9
-
29
-
-
0037223797
-
Prevalence of hepatitis C among psychiatric patients in the public sector
-
DOI 10.1176/appi.ajp.160.1.172
-
Dinwiddie SH, Shicker L, Newman T,. Prevalence of hepatitis C among psychiatric patients in the public sector. Am J Psychiatry 2003; 160 (1): 172-174. (Pubitemid 36042444)
-
(2003)
American Journal of Psychiatry
, vol.160
, Issue.1
, pp. 172-174
-
-
Dinwiddie, S.H.1
Shicker, L.2
Newman, T.3
-
30
-
-
0033584440
-
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
-
DOI 10.1056/NEJM199908193410802
-
Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341 (8): 556-562. (Pubitemid 29384163)
-
(1999)
New England Journal of Medicine
, vol.341
, Issue.8
, pp. 556-562
-
-
Alter, M.J.1
Kruszon-Moran, D.2
Nainan, O.V.3
McQuillan, G.M.4
Gao, F.5
Moyer, L.A.6
Kaslow, R.A.7
Margolis, H.S.8
-
31
-
-
42949150811
-
Declining hepatitis C rates in first-time blood donors: Insight from surveillance and case-control risk factor studies
-
DOI 10.1111/j.1537-2995.2007.01618.x
-
O'Brien SF, Fan W, Xi G, et al. Declining hepatitis C rates in first-time blood donors: insight from surveillance and case-control risk factor studies. Transfusion 2008; 48 (5): 902-909. (Pubitemid 351614899)
-
(2008)
Transfusion
, vol.48
, Issue.5
, pp. 902-909
-
-
O'Brien, S.F.1
Fan, W.2
Xi, G.3
Yi, Q.-L.4
Goldman, M.5
Fearon, M.A.6
Infante-Rivard, C.7
Chiavetta, J.A.8
Willems, B.9
Pi, D.10
Fast, M.11
Delage, G.12
-
32
-
-
73449098125
-
Prevalence of Hepatitis C Infection in New York City, 2004
-
Bornschlegel K, Berger M, Garg RK, et al. Prevalence of Hepatitis C Infection in New York City, 2004. J Urban Health 2009; 86 (6): 909-917.
-
(2009)
J Urban Health
, vol.86
, Issue.6
, pp. 909-917
-
-
Bornschlegel, K.1
Berger, M.2
Garg, R.K.3
-
33
-
-
84855749992
-
-
New York City Department Of Health and Mental Hygiene [cited 2009 Aug. 19]
-
Hepatitis A, B, and C Surveillance Report. New York City Department Of Health and Mental Hygiene [2005 [cited 2009 Aug. 19]; Available from: URL http://www.nyc.gov/html/doh/downloads/pdf/cd/cd-hepabc-surveillancereport.pdf
-
(2005)
Hepatitis A, B, and C Surveillance Report
-
-
-
34
-
-
84855731316
-
-
[45 C.F.R. Part 160]
-
Public Welfare: Subtitle A-Department of Health and Human Services, General Administrative Requirements. http://www hhs gov/ocr/hipaa/finalreg html hhs [2002 45 C.F.R. Part 160 Available from: URL: http://www.hhs.gov/ocr/hipaa/ finalreg.html
-
(2002)
General Administrative Requirements
-
-
-
35
-
-
33846393139
-
-
(45 C.F.R. Part 164, Subparts A and E)
-
Public Welfare: Subtitle A-Department of Health and Human Services, Security and Privacy. http://www hhs gov/ocr/hipaa/finalreg html [2002 (45 C.F.R. Part 164, Subparts A and E) Available from: URL:http://www.hhs.gov/ocr/ hipaa/finalreg.html
-
(2002)
Security and Privacy
-
-
-
36
-
-
33745282710
-
-
Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality RMD
-
Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality RMD. Clinical Classifications Software (CCS). 2007.
-
(2007)
Clinical Classifications Software (CCS)
-
-
-
37
-
-
0037008087
-
Updated definitions of healthy ranges for serum alanine aminotransferase levels
-
Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002; 137 (1): 1-10.
-
(2002)
Ann Intern Med
, vol.137
, Issue.1
, pp. 1-10
-
-
Prati, D.1
Taioli, E.2
Zanella, A.3
-
38
-
-
0034720287
-
Evaluation of abnormal liver-enzyme results in asymptomatic patients
-
DOI 10.1056/NEJM200004273421707
-
Pratt DS, Kaplan MM,. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med 2000; 342 (17): 1266-1271. (Pubitemid 30235957)
-
(2000)
New England Journal of Medicine
, vol.342
, Issue.17
, pp. 1266-1271
-
-
Pratt, D.S.1
Kaplan, M.M.2
-
39
-
-
34250324595
-
A community experience responding to hepatitis C
-
Rude EJ, Weisfuse I,. A community experience responding to hepatitis C. Public Health Rep 2007; 122 (Suppl 2): 89-90. (Pubitemid 47443839)
-
(2007)
Public Health Reports
, vol.122
, Issue.SUPPL. 2
, pp. 89-90
-
-
Rude, E.J.1
Weisfuse, I.2
|